company background image
AMED

Amedisys NasdaqGS:AMED Stock Report

Last Price

US$91.94

Market Cap

US$2.9b

7D

-4.9%

1Y

-31.9%

Updated

07 Feb, 2023

Data

Company Financials +

AMED Stock Overview

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States.

AMED fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance2/6
Financial Health3/6
Dividends0/6

My Notes

New

Notes are coming soon

Amedisys, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Amedisys
Historical stock prices
Current Share PriceUS$91.94
52 Week HighUS$179.91
52 Week LowUS$79.30
Beta1.0
1 Month Change11.31%
3 Month Change8.68%
1 Year Change-31.94%
3 Year Change-52.88%
5 Year Change67.07%
Change since IPO1,651.23%

Recent News & Updates

At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jan 03
At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Dec 16
A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Recent updates

At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jan 03
At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Dec 16
A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal

Nov 12
Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal

Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?

Sep 19
Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?

An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued

Sep 04
An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued

Amedisys: ROIC, Tangible Book Value Each Softening

Aug 24

Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement

Aug 04
Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement

Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates

Jul 27

We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt

Jul 20
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt

At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jun 04
At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled

May 05
Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled

Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?

Apr 20
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?

Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?

Apr 06
Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?

Is Amedisys (NASDAQ:AMED) A Risky Investment?

Feb 20
Is Amedisys (NASDAQ:AMED) A Risky Investment?

Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue

Jan 19
Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

Dec 03
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely

Nov 18
These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely

Amedisys (NASDAQ:AMED) Could Easily Take On More Debt

Aug 18
Amedisys (NASDAQ:AMED) Could Easily Take On More Debt

Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Jul 23
Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity

Jul 18

Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive

Jun 28
Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive

It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package

Jun 02
It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

May 24
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Apr 14
Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Is Amedisys (NASDAQ:AMED) Using Too Much Debt?

Apr 01
Is Amedisys (NASDAQ:AMED) Using Too Much Debt?

Is Amedisys (NASDAQ:AMED) A Future Multi-bagger?

Mar 19
Is Amedisys (NASDAQ:AMED) A Future Multi-bagger?

Bruce Perkins Is The Independent Director of Amedisys, Inc. (NASDAQ:AMED) And They Just Picked Up 3.7% More Shares

Mar 06
Bruce Perkins Is The Independent Director of Amedisys, Inc. (NASDAQ:AMED) And They Just Picked Up 3.7% More Shares

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

Feb 20
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

Shareholders Are Raving About How The Amedisys (NASDAQ:AMED) Share Price Increased 730%

Feb 08
Shareholders Are Raving About How The Amedisys (NASDAQ:AMED) Share Price Increased 730%

How Much Are Amedisys, Inc. (NASDAQ:AMED) Insiders Spending On Buying Shares?

Jan 26
How Much Are Amedisys, Inc. (NASDAQ:AMED) Insiders Spending On Buying Shares?

Are Robust Financials Driving The Recent Rally In Amedisys, Inc.'s (NASDAQ:AMED) Stock?

Jan 13
Are Robust Financials Driving The Recent Rally In Amedisys, Inc.'s (NASDAQ:AMED) Stock?

Shareholder Returns

AMEDUS HealthcareUS Market
7D-4.9%-4.4%0.9%
1Y-31.9%-7.2%-10.9%

Return vs Industry: AMED underperformed the US Healthcare industry which returned -7.2% over the past year.

Return vs Market: AMED underperformed the US Market which returned -10.9% over the past year.

Price Volatility

Is AMED's price volatile compared to industry and market?
AMED volatility
AMED Average Weekly Movement5.5%
Healthcare Industry Average Movement7.7%
Market Average Movement6.7%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: AMED is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: AMED's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198221,000Paul Kusserowhttps://www.amedisys.com

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Amedisys, Inc. Fundamentals Summary

How do Amedisys's earnings and revenue compare to its market cap?
AMED fundamental statistics
Market CapUS$2.93b
Earnings (TTM)US$120.94m
Revenue (TTM)US$2.22b

24.7x

P/E Ratio

1.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AMED income statement (TTM)
RevenueUS$2.22b
Cost of RevenueUS$1.24b
Gross ProfitUS$980.03m
Other ExpensesUS$859.09m
EarningsUS$120.94m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 15, 2023

Earnings per share (EPS)3.72
Gross Margin44.14%
Net Profit Margin5.45%
Debt/Equity Ratio42.4%

How did AMED perform over the long term?

See historical performance and comparison